|
|
FIN 2015
COI 2.83 %
*
Breed relevant health information:
Elbows
normal
-
5/12/2015
Hips
Mild / C1 / 9-12 / C / 26-35
-
4/7/2016
|
FIN 2013
COI 2.34 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
-
8/4/2020
Degenerative myelopathy (DM)
N/N (clear)
-
8/4/2020
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
8/4/2020
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
8/4/2020
|
|
|||
FIN 2012
COI 3.49 %
*
Breed relevant health information:
Elbows
Grades 1/1
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
FIN 2008
COI 1.97 %
*
Breed relevant health information:
Elbows
normal
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2019
Cause of death:
Spondylosis deformans (SP)
|
||
FIN 2009
COI 2.17 %
*
Breed relevant health information:
Elbows
normal
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
|||
|
|
|
|
|
|||
|
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Expected Peter Pan
|
3 Mar 2018 | |||||||||
Myllyvahdin Tuhkimo
|
16 Aug 2019 | |||||||||
Siblings | ||||||||||
Myllyvahdin Elämän Nälkä
|
12 Apr 2022 | |||||||||
Myllyvahdin Haaveissa Vainko Oot Mun
|
12 Apr 2022 | |||||||||
Myllyvahdin Levoton Prinssi
|
12 Apr 2022 | |||||||||
Myllyvahdin Mä En Pelkää
|
12 Apr 2022 | |||||||||
Myllyvahdin Tuuliviiri
|
12 Apr 2022 | |||||||||
Myllyvahdin Vauhti Kiihtyy
|
12 Apr 2022 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Offspring |